BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27153337)

  • 1. Small Mismatches in Fatty Acyl Tail Lengths Can Effect Non Steroidal Anti-Inflammatory Drug Induced Membrane Fusion.
    Majumdar A; Sarkar M
    J Phys Chem B; 2016 Jun; 120(21):4791-802. PubMed ID: 27153337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lipid molecule headgroup mismatch on non steroidal anti-inflammatory drugs induced membrane fusion.
    Mondal Roy S; Sarkar M
    Langmuir; 2011 Dec; 27(24):15054-64. PubMed ID: 21999838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-steroidal anti-inflammatory drug induced membrane fusion: concentration and temperature effects.
    Mondal S; Sarkar M
    J Phys Chem B; 2009 Dec; 113(51):16323-31. PubMed ID: 19954169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of increase in orientational order of lipid chains and head group spacing on non steroidal anti-inflammatory drug induced membrane fusion.
    Roy SM; Bansode AS; Sarkar M
    Langmuir; 2010 Dec; 26(24):18967-75. PubMed ID: 21114267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of non steroidal anti-inflammatory drug induced membrane fusion by copper coordination of these drugs: anchoring effect.
    Majumdar A; Chakraborty S; Sarkar M
    J Phys Chem B; 2014 Dec; 118(48):13785-99. PubMed ID: 25380501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of oxicam NSAIDs with DMPC vesicles: differential partitioning of drugs.
    Chakraborty H; Roy S; Sarkar M
    Chem Phys Lipids; 2005 Dec; 138(1-2):20-8. PubMed ID: 16183046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane fusion: a new function of non steroidal anti-inflammatory drugs.
    Chakraborty H; Mondal S; Sarkar M
    Biophys Chem; 2008 Sep; 137(1):28-34. PubMed ID: 18617319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of piroxicam and meloxicam with DMPG/DMPC mixed vesicles: anomalous partitioning behavior.
    Chakraborty H; Sarkar M
    Biophys Chem; 2007 Feb; 125(2-3):306-13. PubMed ID: 17010502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of Oxicam NSAIDs with lipid monolayer: anomalous dependence on drug concentration.
    Kundu S; Chakraborty H; Sarkar M; Datta A
    Colloids Surf B Biointerfaces; 2009 Apr; 70(1):157-61. PubMed ID: 19157803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Effect of Oxicam Non-Steroidal Anti-Inflammatory Drugs on Membranes and Their Consequence on Membrane Fusion.
    Majumdar A; Kundu D; Sarkar M
    J Phys Chem B; 2015 Jul; 119(30):9627-39. PubMed ID: 26147344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of non-steroid anti-inflammatory drugs in membrane bilayers.
    Kyrikou I; Hadjikakou SK; Kovala-Demertzi D; Viras K; Mavromoustakos T
    Chem Phys Lipids; 2004 Dec; 132(2):157-69. PubMed ID: 15555602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct binding of Cu(II)-complexes of oxicam NSAIDs with DNA backbone.
    Roy S; Banerjee R; Sarkar M
    J Inorg Biochem; 2006 Aug; 100(8):1320-31. PubMed ID: 16684565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of nonsteroidal anti-inflammatory drugs with membranes: in vitro assessment and relevance for their biological actions.
    Pereira-Leite C; Nunes C; Reis S
    Prog Lipid Res; 2013 Oct; 52(4):571-84. PubMed ID: 23981364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of NSAIDs in micelles: implication of structural switchover in drug-membrane interaction.
    Chakraborty H; Banerjee R; Sarkar M
    Biophys Chem; 2003 May; 104(1):315-25. PubMed ID: 12834850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photophysical studies of oxicam group of NSAIDs: piroxicam, meloxicam and tenoxicam.
    Banerjee R; Chakraborty H; Sarkar M
    Spectrochim Acta A Mol Biomol Spectrosc; 2003 Apr; 59(6):1213-22. PubMed ID: 12659890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of new oxicam derivatives with lipid bilayers as measured by calorimetry and fluorescence spectroscopy.
    Maniewska J; Gąsiorowska J; Szczęśniak-Sięga B; Michalak K
    Acta Biochim Pol; 2018; 65(2):185-191. PubMed ID: 29796443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-angle neutron scattering studies of phospholipid-NSAID adducts.
    Boggara MB; Krishnamoorti R
    Langmuir; 2010 Apr; 26(8):5734-45. PubMed ID: 20014785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectroscopic studies of the binding of Cu(II) complexes of oxicam NSAIDs to alternating G-C and homopolymeric G-C sequences.
    Chakraborty S; Bose M; Sarkar M
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Mar; 122():690-7. PubMed ID: 24345609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semi solid matrix formulations of meloxicam and tenoxicam: an in vitro and in vivo evaluation.
    Alladi S; Shastri NR
    Arch Pharm Res; 2015; 38(5):801-12. PubMed ID: 24752862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of Cu(II) complexes of oxicam NSAIDs to alternating AT and homopolymeric AT sequences: differential response to variation in backbone structure.
    Chakraborty S; Sehanobish E; Sarkar M
    J Biol Inorg Chem; 2012 Mar; 17(3):475-87. PubMed ID: 22270943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.